Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FUJST
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,064
Award facts
- Contract value 100% obligated
- $15,063.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive strength in federal pharmaceutical procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million and valid through November 2026. Through this master contract vehicle, DMS Pharmaceutical Group serves as a critical supplier of pharmaceutical products to Department of Defense healthcare facilities nationwide, distributing branded and generic prescription drugs, biologics, and medical consumables. The SPE2DB program enables the DLA to issue firm fixed-price delivery orders for diverse pharmaceutical needs across military medical installations, and this specific award for EXPAREL—a local anesthetic used in surgical and medical applications—reflects the company's ongoing role as a primary pharmaceutical distributor supporting federal healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FUJST?
SPE2DB25FUJST was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FUJST worth?
The government has obligated $15,064 on SPE2DB25FUJST.
Is contract SPE2DB25FUJST an order under another contract?
Yes. SPE2DB25FUJST is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJST competed?
The extent of competition for SPE2DB25FUJST was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award